KONINKLIJKE PHILIPS NV

Pursuant to provisions of the United States Private Securities Litigation

Reform Act of 1995, Philips is providing the following cautionary

statement.

This document, including the information referred to in the Form 20-F

cross reference table, contains certain forward-looking statements with

respect to the financial condition, results of operations and business of

Philips and certain of the plans and objectives of Philips with respect to

these items, in particular, among other statements, certain statements

in Item 4 “Information on the Company” with regard to management's

views and objectives, market trends, market standing, product volumes,

business risks, the statements in Item 5 “Operating and financial review

and prospects” with regards to trends in results of operations, margins

overall, market trends, risk management, exchange rates, the

statements in Item 8 “Financial Information” relating to legal

proceedings and goodwill and statements in Item 11 “Quantitative and

qualitative disclosure about market risks” relating to risk caused by

derivative positions, interest rate fluctuations and other financial

exposure are forward-looking in nature. Forward-looking statements

can be identified generally as those containing words such as

“anticipates”, “assumes”, “believes”, “estimates”, “expects”, “should”,

“will”, “will likely result”, “forecast”, “outlook”, “projects”, “may” or

similar expressions. By their nature, these statements involve risk and

uncertainty because they relate to future events and circumstances and

there are many factors that could cause actual results and

developments to differ materially from those expressed or implied by

these statements. These factors include but are not limited to: macro-

economic and geopolitical changes including protectionism measures

such as enacted and proposed tariffs and retaliatory trade measures in

response thereto; Philips’ ability to keep pace with the changing health

technology environment; Philips’ ability to gain leadership in artificial

intelligence (AI) and health informatics in response to developments in

the health technology industry; integration of acquisitions and their

delivery on business plans and value creation expectations; ability to

meet expectations with respect to ESG-related matters; securing and

maintaining Philips’ intellectual property rights, and unauthorized use

of third-party intellectual property rights; failure of products and

services to meet quality or security standards, adversely affecting

patient safety and customer operations; the resilience of our supply

chain; challenges in simplifying our organization and our ways of

working; attracting and retaining personnel; breach of cybersecurity;

challenges in driving operational excellence and speed in bringing

innovations to market; treasury and financing risks; tax risks; reliability

of internal controls; compliance with regulations and standards

involving quality, product safety, (cyber) security and AI; and

compliance with business conduct rules and regulations including

privacy, existing and upcoming ESG disclosure and due diligence

requirements. As a result, Philips’ actual future results may differ

materially from the plans, goals and expectations set forth in such

forward-looking statements. For a discussion of factors that could cause

future results to differ from such forward-looking statements,

reference is made to the information in Risk factors.

Form 20-F cross reference table